By targeting and inhibiting the expression of CCAAT/enhancer-binding protein beta (C/EBPβ), it promotes epithelial-mesenchymal transition (EMT) and metastasis in breast cancer [19]. The gene discussed is CEBPB; the disease is breast carcinoma.